{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:45:36Z","timestamp":1785174336310,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the General Program of the National Natural Science Foundation of China","award":["82273300"],"award-info":[{"award-number":["82273300"]}]},{"name":"the General Program of the National Natural Science Foundation of China","award":["82072956"],"award-info":[{"award-number":["82072956"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04343-3","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T10:20:59Z","timestamp":1752142859000},"page":"237-247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preoperative thyroglobulin antibody concentrations and prediction of papillary thyroid carcinoma recurrence"],"prefix":"10.1007","volume":"90","author":[{"given":"Jiawei","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik K.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-336X","authenticated-orcid":false,"given":"Haipeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5377-7727","authenticated-orcid":false,"given":"Shubin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"10","key":"4343_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102649","volume":"19","author":"M Ralli","year":"2020","unstructured":"M. Ralli, D. Angeletti, M. Fiore et al., Hashimoto\u2019s thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun. Rev. 19(10), 102649 (2020). https:\/\/doi.org\/10.1016\/j.autrev.2020.102649.","journal-title":"Autoimmun. Rev."},{"issue":"4-5","key":"4343_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"P. Caturegli, A. De Remigis, N.R. Rose, Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun. Rev. 13(4-5), 391\u2013397 (2014). https:\/\/doi.org\/10.1016\/j.autrev.2014.01.007.","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"4343_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1089\/1050725041517057","volume":"14","author":"SM McLachlan","year":"2004","unstructured":"S.M. McLachlan, B. Rapoport, Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies?. Thyroid 14(7), 510\u2013520 (2004). https:\/\/doi.org\/10.1089\/1050725041517057.","journal-title":"Thyroid"},{"issue":"2","key":"4343_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/thy.2012.0554","volume":"23","author":"P Caturegli","year":"2013","unstructured":"P. Caturegli, A. De Remigis, K. Chuang, M. Dembele, A. Iwama, S. Iwama, Hashimoto\u2019s thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid 23(2), 142\u2013150 (2013). https:\/\/doi.org\/10.1089\/thy.2012.0554.","journal-title":"Thyroid"},{"issue":"2","key":"4343_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","volume":"42","author":"DS McLeod","year":"2012","unstructured":"D.S. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2), 252\u2013265 (2012). https:\/\/doi.org\/10.1007\/s12020-012-9703-2.","journal-title":"Endocrine"},{"issue":"1","key":"4343_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"R.L. Siegel, A.N. Giaquinto, A. Jemal, Cancer statistics, 2024. CA Cancer J. Clin. 74(1), 12\u201349 (2024). https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"4343_CR7","doi-asserted-by":"publisher","first-page":"e2440381","DOI":"10.1001\/jamanetworkopen.2024.40381","volume":"7","author":"M Li","year":"2024","unstructured":"M. Li, M. Hu, L. Jiang, J. Pei, C. Zhu, Trends in cancer incidence and potential associated factors in China. JAMA Netw. Open. 7(10), e2440381 (2024). https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.40381.","journal-title":"JAMA Netw. Open."},{"issue":"1","key":"4343_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12146-4","volume":"24","author":"H Wang","year":"2024","unstructured":"H. Wang, C. Zhang, Q. Li et al., Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches. BMC Cancer 24(1), 427 (2024). https:\/\/doi.org\/10.1186\/s12885-024-12146-4.","journal-title":"BMC Cancer"},{"issue":"3","key":"4343_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ejso.2017.07.013","volume":"44","author":"SL Gillanders","year":"2018","unstructured":"S.L. Gillanders, J.P. O\u2019Neill, Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC). Eur. J. Surg. Oncol. 44(3), 286\u2013296 (2018). https:\/\/doi.org\/10.1016\/j.ejso.2017.07.013.","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"4343_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0","volume":"79","author":"FD Gilliland","year":"1997","unstructured":"F.D. Gilliland, W.C. Hunt, D.M. Morris, C.R. Key, Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973\u20131991. Cancer79(3), 564\u2013573 (1997). 10.1002\/(sici)1097-0142(19970201)79:3<564::aid-cncr20>3.0.co;2-0.","journal-title":"Cancer"},{"issue":"2","key":"4343_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ecl.2014.02.010","volume":"43","author":"DP Momesso","year":"2014","unstructured":"D.P. Momesso, R.M. Tuttle, Update on differentiated thyroid cancer staging. Endocrinol. Metab. Clin. North. Am. 43(2), 401\u2013421 (2014). https:\/\/doi.org\/10.1016\/j.ecl.2014.02.010.","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"1","key":"4343_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.surg.2018.04.078","volume":"165","author":"AR Shaha","year":"2019","unstructured":"A.R. Shaha, J.C. Migliacci, I.J. Nixon et al., Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer. Surgery 165(1), 6\u201311 (2019). https:\/\/doi.org\/10.1016\/j.surg.2018.04.078.","journal-title":"Surgery"},{"issue":"1","key":"4343_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/jco.2014.56.8253","volume":"33","author":"M Xing","year":"2015","unstructured":"M. Xing, A.S. Alzahrani, K.A. Carson et al., Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J. Clin. Oncol. 33(1), 42\u201350 (2015). https:\/\/doi.org\/10.1200\/jco.2014.56.8253.","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"4343_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1530\/EJE-12-0903","volume":"168","author":"JH Lee","year":"2013","unstructured":"J.H. Lee, Y. Kim, J.W. Choi, Y.S. Kim, The association between papillary thyroid carcinoma and histologically proven Hashimoto\u2019s thyroiditis: a meta-analysis. Eur. J. Endocrinol. 168(3), 343\u2013349 (2013). https:\/\/doi.org\/10.1530\/EJE-12-0903.","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"4343_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/thy.2010.0050","volume":"21","author":"K Mukasa","year":"2011","unstructured":"K. Mukasa, J.Y. Noh, Y. Kunii et al., Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases. Thyroid 21(1), 37\u201341 (2011). https:\/\/doi.org\/10.1089\/thy.2010.0050.","journal-title":"Thyroid"},{"issue":"4","key":"4343_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1210\/js.2018-00427","volume":"3","author":"N Silva de Morais","year":"2019","unstructured":"N. Silva de Morais, J. Stuart, H. Guan et al., The impact of Hashimoto thyroiditis on thyroid nodule cytology and risk of thyroid cancer. J. Endocr. Soc. 3(4), 791\u2013800 (2019). https:\/\/doi.org\/10.1210\/js.2018-00427.","journal-title":"J. Endocr. Soc."},{"key":"4343_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2017.00053","volume":"7","author":"C Resende de Paiva","year":"2017","unstructured":"C. Resende de Paiva, C. Gr\u00f8nh\u00f8j, U. Feldt-Rasmussen, C. von Buchwald, Association between Hashimoto\u2019s thyroiditis and thyroid cancer in 64,628 patients. Front. Oncol. 7, 53 (2017). https:\/\/doi.org\/10.3389\/fonc.2017.00053.","journal-title":"Front. Oncol."},{"issue":"4","key":"4343_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1089\/thy.2019.0347","volume":"30","author":"RD Paparodis","year":"2020","unstructured":"R.D. Paparodis, E. Karvounis, D. Bantouna et al., Incidentally discovered papillary thyroid microcarcinomas are more frequently found in patients with chronic lymphocytic thyroiditis than with multinodular goiter or Graves\u2019 disease. Thyroid\u00ae 30(4), 531\u2013535 (2020). https:\/\/doi.org\/10.1089\/thy.2019.0347.","journal-title":"Thyroid\u00ae"},{"issue":"3","key":"4343_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10147-014-0754-7","volume":"20","author":"HY Kwak","year":"2015","unstructured":"H.Y. Kwak, B.J. Chae, Y.H. Eom et al., Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?. Int. J. Clin. Oncol. 20(3), 463\u2013473 (2015). https:\/\/doi.org\/10.1007\/s10147-014-0754-7.","journal-title":"Int. J. Clin. Oncol."},{"issue":"6","key":"4343_CR20","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1210\/jc.2013-1309","volume":"98","author":"S Dvorkin","year":"2013","unstructured":"S. Dvorkin, E. Robenshtok, D. Hirsch, Y. Strenov, I. Shimon, C.A. Benbassat, Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J. Clin. Endocrinol. Metab. 98(6), 2409\u20132414 (2013). https:\/\/doi.org\/10.1210\/jc.2013-1309.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4343_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fendo.2017.00337","volume":"8","author":"A Ieni","year":"2017","unstructured":"A. Ieni, R. Vita, E. Magliolo et al., One-third of an archivial series of papillary thyroid cancer (Years 20 07\u20132015) has coexistent chronic lymphocytic thyroiditis, which is associated with a more favorable tumor-node-metastasis staging. Front. Endocrinol. 8, 337 (2017). https:\/\/doi.org\/10.3389\/fendo.2017.00337.","journal-title":"Front. Endocrinol."},{"key":"4343_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1349041","volume":"15","author":"H Zhang","year":"2024","unstructured":"H. Zhang, L. Tian, X. Wang, X. Shi, The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis. Front. Endocrinol. 15, 1349041 (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1349041.","journal-title":"Front. Endocrinol."},{"issue":"1","key":"4343_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible et al., 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1\u2013133 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid"},{"issue":"12","key":"4343_CR24","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1210\/jc.2011-1740","volume":"96","author":"CA Spencer","year":"2011","unstructured":"C.A. Spencer, Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J. Clin. Endocrinol. Metab. 96(12), 3615\u20133627 (2011). https:\/\/doi.org\/10.1210\/jc.2011-1740.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4343_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/thy.1998.8.197","volume":"8","author":"K Kashima","year":"1998","unstructured":"K. Kashima, S. Yokoyama, S. Noguchi et al., Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 8(3), 197\u2013202 (1998). https:\/\/doi.org\/10.1089\/thy.1998.8.197.","journal-title":"Thyroid"},{"issue":"3","key":"4343_CR26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s12020-013-0121-x","volume":"46","author":"X Wu","year":"2014","unstructured":"X. Wu, Y. Lun, H. Jiang et al., Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer. Endocrine 46(3), 554\u2013560 (2014). https:\/\/doi.org\/10.1007\/s12020-013-0121-x.","journal-title":"Endocrine"},{"issue":"4","key":"4343_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.eprac.2020.10.017","volume":"27","author":"L Li","year":"2021","unstructured":"L. Li, T. Shan, X. Sun et al., Positive thyroid peroxidase antibody and thyroglobulin antibody are associated with better clinicopathologic features of papillary thyroid cancer. Endocr. Pract. 27(4), 306\u2013311 (2021). https:\/\/doi.org\/10.1016\/j.eprac.2020.10.017.","journal-title":"Endocr. Pract."},{"issue":"6","key":"4343_CR28","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/ijc.31944","volume":"144","author":"E Song","year":"2019","unstructured":"E. Song, H.S. Oh, M.J. Jeon et al., The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma. Int. J. Cancer 144(6), 1414\u20131420 (2019). https:\/\/doi.org\/10.1002\/ijc.31944.","journal-title":"Int. J. Cancer"},{"issue":"7","key":"4343_CR29","doi-asserted-by":"publisher","first-page":"e2118526","DOI":"10.1001\/jamanetworkopen.2021.18526","volume":"4","author":"S Xu","year":"2021","unstructured":"S. Xu, H. Huang, J. Qian et al., Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes. JAMA Netw. Open. 4(7), e2118526 (2021). https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.18526.","journal-title":"JAMA Netw. Open."},{"issue":"2","key":"4343_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1210\/jc.2007-1199","volume":"93","author":"F Latrofa","year":"2008","unstructured":"F. Latrofa, D. Ricci, L. Grasso et al., Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies. J. Clin. Endocrinol. Metab. 93(2), 591\u2013596 (2008). https:\/\/doi.org\/10.1210\/jc.2007-1199.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4343_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.beem.2013.07.003","volume":"27","author":"C Spencer","year":"2013","unstructured":"C. Spencer, S. Fatemi, Thyroglobulin antibody (TgAb) methods - strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer. Best. Pract. Res. Clin. Endocrinol. Metab. 27(5), 701\u2013712 (2013). https:\/\/doi.org\/10.1016\/j.beem.2013.07.003.","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"4343_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1354426","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Y. Zhao, Z. Mu, D. Liang et al., Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer. Front. Endocrinol. 15, 1354426 (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1354426.","journal-title":"Front. Endocrinol."},{"issue":"10","key":"4343_CR33","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1089\/thy.2019.0791","volume":"30","author":"N Yin","year":"2020","unstructured":"N. Yin, S.I. Sherman, Y. Pak, D.R. Litofsky, A.G. Gianoukakis, The de novo detection of anti-thyroglobulin antibodies and differentiated thyroid cancer recurrence. Thyroid 30(10), 1490\u20131495 (2020). https:\/\/doi.org\/10.1089\/thy.2019.0791.","journal-title":"Thyroid"},{"issue":"9","key":"4343_CR34","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/jc.2017-00286","volume":"102","author":"AJ Wassner","year":"2017","unstructured":"A.J. Wassner, M. Della Vecchia, P. Jarolim, H.A. Feldman, S.A. Huang, Prevalence and significance of thyroglobulin antibodies in pediatric thyroid cancer. J. Clin. Endocrinol. Metab. 102(9), 3146\u20133153 (2017). https:\/\/doi.org\/10.1210\/jc.2017-00286.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4343_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02914-7","volume":"21","author":"G Li","year":"2023","unstructured":"G. Li, L. He, J. Huang et al., miR-142-3p encapsulated in T lymphocyte-derived tissue small extracellular vesicles induces Treg function defect and thyrocyte destruction in Hashimoto\u2019s thyroiditis. BMC Med. 21(1), 206 (2023). https:\/\/doi.org\/10.1186\/s12916-023-02914-7.","journal-title":"BMC Med."},{"issue":"2","key":"4343_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1089\/thy.2017.0286","volume":"28","author":"X Yang","year":"2018","unstructured":"X. Yang, Y. Lun, H. Jiang et al., SIRT1-regulated abnormal acetylation of FOXP3 induces regulatory T-Cell function defect in Hashimoto\u2019s thyroiditis. Thyroid 28(2), 246\u2013256 (2018). https:\/\/doi.org\/10.1089\/thy.2017.0286.","journal-title":"Thyroid"},{"issue":"9","key":"4343_CR37","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1210\/jc.2005-2337","volume":"91","author":"M Marazuela","year":"2006","unstructured":"M. Marazuela, M.A. Garc\u00eda-L\u00f3pez, N. Figueroa-Vega et al., Regulatory T cells in human autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 91(9), 3639\u20133646 (2006). https:\/\/doi.org\/10.1210\/jc.2005-2337.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4343_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2024.102596","volume":"91","author":"H Ding","year":"2024","unstructured":"H. Ding, J. Qin, Z. Liu, X. Shi, W. Guan, J. Sang, Mesenchymal stem cells alleviate autoimmune thyroiditis by modulating macrophage phenotypes and through influencing the STING pathway. Tissue Cell 91, 102596 (2024). https:\/\/doi.org\/10.1016\/j.tice.2024.102596.","journal-title":"Tissue Cell"},{"issue":"8","key":"4343_CR39","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1089\/thy.2009.0384","volume":"20","author":"ES Kim","year":"2010","unstructured":"E.S. Kim, D.J. Lim, K.H. Baek et al., Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 20(8), 885\u2013891 (2010). https:\/\/doi.org\/10.1089\/thy.2009.0384.","journal-title":"Thyroid"},{"issue":"3","key":"4343_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.prp.2016.12.022","volume":"213","author":"W Li","year":"2017","unstructured":"W. Li, H. Ming, D. Sun et al., The relationship between BRAFV600E, NF-\u03baB and TgAb expression in papillary thyroid carcinoma. Pathol. Res. Pract. 213(3), 183\u2013188 (2017). https:\/\/doi.org\/10.1016\/j.prp.2016.12.022.","journal-title":"Pathol. Res. Pract."},{"issue":"9","key":"4343_CR41","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1210\/jc.2014-1250","volume":"99","author":"TH Collet","year":"2014","unstructured":"T.H. Collet, D.C. Bauer, A.R. Cappola et al., Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis. J. Clin. Endocrinol. Metab. 99(9), 3353\u20133362 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1250.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4343_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.833775","volume":"12","author":"Y Gui","year":"2022","unstructured":"Y. Gui, D. Huang, Y. Hou, X. Wei, J. Zhang, J. Wang, Predictive factors for recurrence of papillary thyroid carcinoma in children and adolescents. Front. Oncol. 12, 833775 (2022). https:\/\/doi.org\/10.3389\/fonc.2022.833775.","journal-title":"Front. Oncol."},{"issue":"1","key":"4343_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/thy.2013.0062","volume":"24","author":"DS McLeod","year":"2014","unstructured":"D.S. McLeod, D.S. Cooper, P.W. Ladenson et al., Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis. Thyroid 24(1), 35\u201342 (2014). https:\/\/doi.org\/10.1089\/thy.2013.0062.","journal-title":"Thyroid"},{"issue":"2","key":"4343_CR44","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12020-022-03283-6","volume":"80","author":"S Xu","year":"2023","unstructured":"S. Xu, H. Huang, J. Qian et al., Prognostic value of the preoperative and early trends in postoperative serum thyroglobulin antibody levels among patients with papillary thyroid carcinoma and concomitant Hashimoto\u2019s thyroiditis. Endocrine 80(2), 392\u2013398 (2023). https:\/\/doi.org\/10.1007\/s12020-022-03283-6.","journal-title":"Endocrine"},{"key":"4343_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1339473","volume":"15","author":"H Ma","year":"2024","unstructured":"H. Ma, G. Li, D. Huo et al., Impact of Hashimoto\u2019s thyroiditis on the tumor microenvironment in papillary thyroid cancer: insights from single-cell analysis. Front. Endocrinol. 15, 1339473 (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1339473.","journal-title":"Front. Endocrinol."},{"issue":"1","key":"4343_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28120-2","volume":"13","author":"QY Zhang","year":"2022","unstructured":"Q.Y. Zhang, X.P. Ye, Z. Zhou et al., Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto\u2019s thyroiditis. Nat. Commun. 13(1), 775 (2022). https:\/\/doi.org\/10.1038\/s41467-022-28120-2.","journal-title":"Nat. Commun."},{"issue":"11","key":"4343_CR47","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1089\/thy.2023.0052","volume":"33","author":"S De Leo","year":"2023","unstructured":"S. De Leo, S. D\u2019Elia, G. Grani et al., A prospective multicenter study examining the relationship between thyroid cancer treatment outcomes and the presence of autoimmune thyroiditis. Thyroid 33(11), 1318\u20131326 (2023). https:\/\/doi.org\/10.1089\/thy.2023.0052.","journal-title":"Thyroid"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04343-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:00:49Z","timestamp":1758772849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4343"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04343-3","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Research Ethics Committee of the First Affiliated Hospital, Sun Yat-sen University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}